AA
GILD icon

Altman Advisors’s Gilead Sciences GILD Stock Holding History

Altman Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77M Sell
21,931
-61
-0.3% -$8.04K 0.99% 31
2026
Q1 		$3.07M Sell
21,992
-513
-2% -$71.8K 1.27% 20
2025
Q4 		$2.76M Buy
22,505
+186
+0.8% +$22.6K 1.04% 33
2025
Q3 		$2.48M Buy
22,319
+333
+2% +$37.9K 0.95% 41
2025
Q2 		$2.46M Buy
21,986
+716
+3% +$76.2K 1% 34
2025
Q1 		$2.27M Buy
21,270
+317
+2% +$32.7K 1.04% 28
2024
Q4 		$1.94M Buy
20,953
+78
+0.4% +$7.02K 0.83% 47
2024
Q3 		$1.75M Buy
20,875
+253
+1% +$19.3K 0.78% 62
2024
Q2 		$1.41M Buy
20,622
+554
+3% +$37K 0.8% 62
2024
Q1 		$1.46M Buy
20,068
+877
+5% +$67.4K 0.71% 72
2023
Q4 		$1.55M Sell
19,191
-132
-0.7% -$10.3K 0.82% 52
2023
Q3 		$1.45M Buy
+19,323
New +$1.49M 0.9% 39
2023
Q1 		$1.34M Buy
19,145
+364
+2% +$30.1K 1.23% 29
2022
Q4 		$1.64M Sell
18,781
-658
-3% -$52.1K 1.01% 27
2022
Q3 		$1.2M Buy
+19,439
New +$1.23M 0.76% 46
2020
Q4 		– Sell
-6,054
Closed -$383K – 85
2020
Q3 		$383K Sell
6,054
-24,723
-80% -$1.71M 0.27% 73
2020
Q2 		$2.37M Sell
30,777
-75
-0.2% -$5.75K 2.01% 18
2020
Q1 		$2.31M Buy
+30,852
New +$2.13M 2.14% 9

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Altman Advisors's GILD Position: Q2 2026 in Review

Altman Advisors reduced its Gilead Sciences (GILD) stake by 0.28% in Q2 2026, selling an estimated $8.04K and leaving 21,931 shares worth $2.77M. The position accounts for 0.99% of the portfolio, ranked #31.

Altman Advisors first reported a position in GILD in Q1 2020 and has held it in 18 quarters since. The position peaked at $3.07M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Altman Advisors held 21,931 shares of Gilead Sciences worth $2.77M as of Q2 2026.
  • Altman Advisors sold 61 Gilead Sciences shares in Q2 2026, an estimated $8.04K.
  • Gilead Sciences made up 0.99% of Altman Advisors's portfolio in Q2 2026, its #31 holding.
  • Altman Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 18 quarters since.
  • Altman Advisors's Gilead Sciences position peaked at $3.07M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Altman Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.